Definium Therapeutics Statistics

NASDAQ: DFTXHealth Care Medicinal Chemicals and Botanical Products USD

35.09-0.53 (-1.49%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 35.07 -0.06%

Definium Therapeutics by the numbers

Definium Therapeutics has a market capitalization of $4.71 billion based on 134.37M shares outstanding. With trailing EPS of $-3.43, Definium Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.1% below its 50-day average and 26.9% above its 200-day average.

Average daily trading volume is 2.15M shares, or about $75.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DFTX valuation vs. peer median

DFTX compared with the median of 8 peer companies
Metric	DFTX	Peer median	Difference
Market cap	$4.71B	$438.64M	+975%
Avg. volume	2.15M	1.43M	+50%

Peer median across 8 companies: TRLV, CRON, TLRY, GLAS, CGC, OBIO, SNDL, ACB.

Valuation

Market cap: $4.71B
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-3.43
Shares outstanding: 134.37M

Price and trading

Previous close: 35.62
Open: 35.34
Day range: 34.92 – 36.39
52-week range: 10.47 – 49.70
52-week change: +193.15%
50-day moving average: 40.85
200-day moving average: 27.65
Beta: —
Volume: 1.97M
Average volume: 2.15M

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 5, 2026

Additional statistics

Market Cap: 4.71B
Forward Pe: -18.45
Eps: -3.43
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 49.70
Week52 Low: 10.47
Avg Volume: 2.15M
Shares Outstanding: 134.37M
Ma50: 40.85
Ma200: 27.65
Earnings Date: Nov 5, 2026
Pct From52w High: -29.40%
Pct From52w Low: 235.31%